Literature DB >> 31707345

Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms.

Wei-Jun Huang1, Wei-Jing Liu1, Yong-Hua Xiao2, Hui-Juan Zheng1, Yao Xiao2, Qi Jia1, Han-Xue Jiang1, Ze-Bing Zhu1, Chen-Hui Xia1, Xue-Ting Han1, Rui-Xi Sun2, He Nan2, Zheng-Dong Feng1, Shi-Dong Wang3, Jin-Xi Zhao4.   

Abstract

Diabetic nephropathy (DN) is a common but intractable diabetic microvascular complication. Tripterygium, a Chinses herb, has been proven to be effective for DN treatment. In this review, the efficacy and pharmacological mechanism of tripterygium and its extracts on DN is elucidated. Tripterygium and its extracts could effectively reduce urine protein and protect renal function. Its pharmacological mechanism involves anti-inflammation, anti-oxidation, anti-glomerulosclerosis and anti-fibrosis, which is achieved by balancing the Th1/Th2 cells, regulating macrophage infiltration, and regulating the following pathways: p38 MAPK, NF-κB, TGF-β, Wnt/β-catenin, Akt and Notch1. Although tripterygium and its extracts may result in some adverse effects, including liver-function damage, gastrointestinal reaction, menstrual disorders, and reproductive problems, they are considered good alternative medicines for DN if used with caution and in the proper manner.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Efficacy; Pharmacological mechanism; Tripterygium

Mesh:

Substances:

Year:  2019        PMID: 31707345     DOI: 10.1016/j.biopha.2019.109599

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Effects of Metformin on Renal Function, Cardiac Function, and Inflammatory Response in Diabetic Nephropathy and Its Protective Mechanism.

Authors:  Zhiping Zhang; Hongyu Dong; Jiaqi Chen; Min Yin; Feng Liu
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

2.  Yiqi Huoxue Recipe Regulates Autophagy through Degradation of Advanced Glycation End Products via mTOR/S6K1/LC3 Pathway in Diabetic Nephropathy.

Authors:  Liang Chen; Linghao Dai; Yi Liu; Xinyue Li; Hui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

3.  A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.

Authors:  Yuyang Wang; Tongtong Liu; Fang Ma; Xiaoguang Lu; Huimin Mao; Weie Zhou; Liping Yang; Ping Li; Yongli Zhan
Journal:  J Diabetes Res       Date:  2020-11-20       Impact factor: 4.011

4.  Isoliquiritigenin prevents hyperglycemia-induced renal injuries by inhibiting inflammation and oxidative stress via SIRT1-dependent mechanism.

Authors:  Xiaozhong Huang; Yujuan Shi; Hongjin Chen; Rongrong Le; Xiaohua Gong; Ke Xu; Qihan Zhu; Feixia Shen; Zimiao Chen; Xuemei Gu; Xiaojun Chen; Xiong Chen
Journal:  Cell Death Dis       Date:  2020-12-07       Impact factor: 8.469

5.  TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis.

Authors:  Xiao-Yong Yu; Qian Sun; Ya-Mei Zhang; Liang Zou; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

6.  Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification.

Authors:  Jiayi Yang; Li Peng; Yuqiu Tian; Wenbin Tang; Linlin Peng; Jianping Ning; Dongjie Li; Yun Peng
Journal:  J Immunol Res       Date:  2022-08-12       Impact factor: 4.493

7.  Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis.

Authors:  Xiaosheng Li; Jie Zheng; Jian Wang; Xianhu Tang; Fengxia Zhang; Shufeng Liu; Yunqiang Liao; Xiaoqing Chen; Wenjuan Xie; Yang Tang
Journal:  Drug Des Devel Ther       Date:  2022-08-03       Impact factor: 4.319

8.  Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway.

Authors:  Yan-Ni Wang; Hong-Jiao Liu; Li-Li Ren; Ping Suo; Liang Zou; Ya-Mei Zhang; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

9.  Astragalus mongholicus Bunge and Panax notoginseng formula (A&P) improves renal mesangial cell damage in diabetic nephropathy by inhibiting the inflammatory response of infiltrated macrophages.

Authors:  Xiao Lin; Xiao-Qin Lei; Jie-Ke Yang; Jian Jia; Xia Zhong; Rui-Zhi Tan; Li Wang
Journal:  BMC Complement Med Ther       Date:  2022-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.